Cipla Ltd is set to invest ZAR 900 million in its wholly-owned subsidiary, Cipla Medpro South Africa Proprietary Ltd. The ...

Mumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro ...

The shares of the third largest pharmaceutical firm Cipla rose 2.44 per cent at Rs 1,454.20 a piece on the BSE intraday after ...

CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical ...

Pharma major Cipla Ltd on Monday said it will invest about ZAR 900 million (nearly Rs 415 crore) in equity share capital of its South African arm Cipla Medpro ...

The company reported a 48% year-on-year (y-o-y) jump in its consolidated net profit to ₹1,571 crore in October-December, ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

In 1952, the pharmaceutical company opened its ... supplement brand Endura Mass from Medinnbelle Herbalcare. Products and services Cipla is among India’s biggest manufacturers of generic drugs ...

Asit C Mehta recommended accumulate rating on Cipla with a target price of Rs 1808 in its research report dated January 17 ...

There's not much margin in PEPFAR products sold by Cipla." The company's stock rose 3% after the results, offseting the 1% decline on Monday after the U.S. funding pause. The pharma index ...

Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by ...

Motilal Oswal retains Neutral on Cipla; see limited upside due to delayed niche product approvals. Learn more about the ...